Puramed Bioscience Inc.
CIK 0001409565
Revenue (TTM)
$3.64K
−100.0% YoY
Q1 Nov 2014
Net Income (TTM)
−$4.38M
−103.9% YoY
Q1 Nov 2014
EPS Diluted (TTM)
—
Q1 Nov 2014
Gross Margin
-11,467.0%
Q1 Nov 2014
Operating Margin
-61,947.4%
Q1 Nov 2014
Net Margin
-120,457.1%
Q1 Nov 2014
Free Cash Flow (TTM)
−$1.09M
Q1 Nov 2014
Cash
—
Q1 Nov 2014
Total Debt
$532.72K
Q1 Nov 2014
Shares Outstanding
199.82M sh
Q1 Nov 2014